|Articles|June 9, 2008
NCCN compendium gains recognition for national coverage decisions
CMS recognizes the NCCN compendium as a source for determining whether a cancer drug or biologic should be covered.
Advertisement
The Centers for Medicare & Medicaid Services has given its blessing to the NCCN Drugs & Biologics Compendium. This resource will now be used as a reference for establishing national coverage decisions for cancer drugs and biologics. The compendium will also be consulted for off-label uses. The CMS decision follows a similar announcement made recently by UnitedHealthCare, which stated that it would use the compendium from the
To see more Daily News articles,